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Abstract
Background: Ultrasound has been shown to increase the efficiency of gene expression from retroviruses,
adenoviruses and adeno-associated viruses. The effect of ultrasound to stimulate cell membrane permeabilization
on infection with an oncolytic herpes simplex virus type 1 (HSV-1) was examined.
Results: Vero monkey kidney cells were infected with HSV-1 and exposed to 1 MHz ultrasound after an adsorption
period. The number of plaques was significantly greater than that of the untreated control. A combination of
ultrasound and microbubbles further increased the plaque number. Similar results were obtained using a different
type of HSV-1 and oral squamous cell carcinoma (SCC) cells. The appropriate intensity, duty cycle and time of
ultrasound to increase the plaque number were 0.5 W/cm
2, 20% duty cycle and 10 sec, respectively. Ultrasound
with microbubbles at an intensity of 2.0 W/cm
2, at 50% duty cycle, or for 40 sec reduced cell viability.
Conclusion: These results indicate that ultrasound promotes the entry of oncolytic HSV-1 into cells. It may be
useful to enhance the efficiency of HSV-1 infection in oncolytic virotherapy.
Background
Oncolytic virotherapy is a novel way to destroy tumor
cells using the cytopathic effect of non-virulent viruses
[1-4]. Herpes simplex virus type 1 (HSV-1) vectors that
lack the neurotoxic gene g134.5 have been developed and
several vectors are under clinical trials [5-7]. A draw back
of oncolytic virotherapy for solid tumors is the efficiency
of infection. Many factors affect an infection. One impor-
tant characteristic of the tumor microenvironment is the
combination of a leaky vasculature and a lack of func-
tional lymphatics, which can create increased interstitial
fluid pressures [8,9]. Additional factors in the extracellu-
lar matrix of tumors can limit interstitial transport and as
a result, further prevent the sufficient and uniform distri-
bution of anti-cancer agents, especially large agents such
as virus vectors [10,11]. The most reliable way to deliver
oncolytic HSV-1 to solid tumors is direct inoculation,
through a more efficient method of delivering HSV-1 to
each tumor cell is required [7].
Ultrasound has been used diagnostically and therapeu-
tically for decades, and its safety is well established
[12,13]. Moreover, ultrasound as a means of stimulating
cell membrane permeabilization, sonoporation, offers
advantages over other technologies, primarily as a result
of its relatively non-invasive nature [14,15]. It enhances
the antitumor effect of chemotherapeutic agents and the
delivery of plasmid DNA in vitro and in vivo [16,17]. The
transiently increased permeability of the cell membrane
is one of the mechanisms of ultrasound-enhanced che-
motherapy. Usually, microbulles increased the efficiency
of ultrasound exposure. Furthermore, ultrasound has
been shown to increase the efficiency of gene expression
from retroviruses, adenoviruses and adeno-associated
viruses (AVVs) [18-21]. However, this method has not
been applied to relatively large enveloped DNA viruses
such as HSV-1. In the present study, we examined
whether the infection of oncolytic HSV-1 is affected by
ultrasound in the presence or absence of microbubbles.
Materials and methods
Cell culture and virus
The human oral squamous cell carcinoma (SCC) cell line
SAS was obtained from the Japanese Collection of
Research Bioresources (Tokyo, Japan). SAS cells were
cultured in Dulbecco’s modified Eagle’sm e d i u m
(DMEM) supplemented with 10% fetal bovine serum,
2 mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml
* Correspondence: yura@dent.osaka-u.ac.jp
Department of Oral and Maxillofacial Surgery, Osaka University Graduate
School of Dentistry, 1-8 Yamadaoka, Suita, Osaka 565-0871, Japan
Shintani et al. Virology Journal 2011, 8:446
http://www.virologyj.com/content/8/1/446
© 2011 Shintani et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.s t r e p t o m y c i na n dg r o w ni na ni n c u b a t o ra t3 7 ° Ci na
humidified atmosphere with 5% CO2.F o rV e r om o n k e y
kidney cells, Eagle’s minimal essential medium contain-
ing 5% calf serum and 2 mM L-glutamine was used. The
H S V - 1m u t a n tR 8 4 9[ 2 2 ]a n dH F[ 2 3 , 2 4 ]w e r eg r o w ni n
semi-confluent Vero cell monolayers. Infected cells were
subjected to three cycles of freezing and thawing and
then centrifuged at 3,000 × g for 15 min at 4°C. The
supernatant was kept at -80°C prior to use.
Plaque assay
Cell monolayers were infected with virus serially diluted
10-fold. After an adsorption period of 60 min, unad-
sorbed viruses were removed by washing cell monolayers
with phosphate-buffered saline (PBS) and then covered
with medium containing 0.3% methylcellulose. They
were incubated at 37°C in a humidified atmosphere with
5% CO2 for approximately 48 h. After the development
of cytopathic effect, the cells were fixed in methanol, and
stained by 1% crystal violet. The numbers of plaques was
counted and plaque forming units (PFU)/ml were deter-
mined [25].
Reagents and plates
As a microbubble, AS-0100 (Artison, Inola, OK) was used.
This lipid-shelled ultrasound contrast agent filled with
perfluorocarbon gas is composed of 9.8 × 10
8 microbub-
bles/ml, having an average diameter of 2.4 μm. A 24-well
plate with a lumox ™ fluorocarbon film base was pur-
chased from Greiner bio-one (Gottingen, Germany). The
thickness of the gas-permeable film was 50 μm.
Ultrasound
An ultrasound machine, Sonitron 2000 V (NEPAGENE
Japan, Chiba, Japan), was used. The cells were grown onto
alternate 24-well polystylene plates (Corning, NY) to pre-
vent the exposure of neighboring cells [26]. Confluent cell
monolayers were infected with 50 or 100 PFU of HSV-1.
For sonoporation in the presence of microbubbles, virus in
90 μl of DMEM was mixed with microbubbles (9.8 × 10
6/
10 μl), after which the mixture was added to the cell cul-
tures. The transducer was firmly fixed to a stand to avoid
dislocation during exposure to ultrasound and the plates
were placed on the head of the transducer with a diameter
of 12 mm and contact was mediated using an ultrasound
contact gel. After a period of viral adsorption, cells were
exposed to ultrasound in the presence or absence of
microbubbles. The ultrasound frequency was 1 MHz
throughout the experiments. In an initial experiment,
the ultrasound was adjusted to supply an intensity of
1.0 W/cm
2 (spatial average temporal peak) at a duty cycle
of 10% (the pulse repetition rate, 100 Hz) for 20 sec. To
determine optimal conditions, the parameters including
intensity, duty cycle and period of exposure were changed.
After the exposure, the mixture was removed and the cells
were washed with PBS and subjected to a plaque forma-
tion assay. Experiments were divided into groups: virus
infection only (Control); infection in the presence of
microbubbles (MB); infection with ultrasound (US); infec-
tion with ultrasound in the presence of microbubbles
(MB + US).
In the experiments to determine cell viability, disso-
ciated cells (1 × 10
6/900 μl) were mixed with microbub-
bles (9.8 × 10
7/100 μl) and suspended in 48-well plates.
After ultrasound, 1 × 10
4 cells were inoculated in 96-
well plates.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium
bromide (MTT) assay
Cells inoculated in 96-well plates were incubated for 48 h.
Thereafter, 10 μl of a 5 mg/ml MTT (Sigma, St.Louis,
MO) solution was added to each well with 100 μl of med-
ium and cells were incubated at 37°C for 4 h. After the
addition of 100 μl of 0.04 N HCl in isopropanol, the plates
were mixed thoroughly to dissolve the dark blue crystal
and stood at room temperature overnight. The plates were
read on a Benchmark Plus microplate spectrophotometer
(Bio-Rad Laboratories, Hercules) with a reference wave-
length of 630 nm and a test wavelength of 570 nm. Back-
ground absorbance at 630 nm was subtracted from the
570 nm reading. The values were divided by that of the
control and the rate was calculated.
Statistical analysis
All values were expressed as the mean ± SD. An Anova
test was used to determine the significance of differences
in multiple comparisons. The Mann-Whitney U-test was
used to compare plaque numbers and cell viability
between each treatment group and the control, and
between the ultrasound group and ultrasound with
microbubble group. These statistical analyses were per-
formed using the software Statcel2, version 2 (OMS,
Tokyo, Japan). A value of P < 0.05 was considered to be
statistically significant.
Results
Effect of microbubbles on the infectivity of HSV-1
Whether microbubbles, AS-0100, could affect the infectiv-
ity of HSV-1 R849 was examined. Microbubbles (9.8 ×
10
7/100 μl) were mixed with viral solution (1 × 10
7 PFU/
900 μl). These mixtures were placed at 4°C. After an incu-
bation for 10, 30, or 60 min, the mixtures were serially
diluted with cold PBS and subjected to plaque assays on
Vero cell monolayers. It was found that the plaque num-
bers in the mixtures incubated at 4°C for 60 min were not
significantly decreased (Figure 1). When 3 × 10
7 PFU of
another HSV-1 strain, HF, were mixed with microbubbles,
no significant reduction in plaque numbers was observed.
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Vero cell monolayers
Since viruses attach to the cell surface and enter into cells
in a time-dependent manner, the number of plaques
increases on prolonging the adsorption period. To deter-
mine the effect of ultrasound on viral entry, Vero cells
were inoculated with 100 PFU of R849 with or without
microbubbles. After incubation at 37°C, infected cells
were exposed to ultrasound and then unadsorbed viruses
were removed and cells were incubated for plaque forma-
tion. The intensity, duty cycle and exposure time were
1.0 W/cm
2, 10% and 20 sec, respectively. In the cultures
exposed to ultrasound after 10, 30 or 60 min of adsorp-
tion, mean plaque numbers were increased 1.2-fold,
1.5-fold and 1.3-fold as compared with the control,
respectively (Figure 2). In the presence of microbubbles,
the increases by ultrasound after 10, 30 or 60 min were
1.9-fold, 1.8-fold and 1.4-fold as compared with the con-
trol, respectively. There was a significant difference
between the control group and ultrasound group (P <
0.05) or ultrasound with microbubbule group (P < 0.01).
A significant difference (P < 0.05) was also observed
between the ultrasound group and ultrasound with
microbubble group. There was no increase in the experi-
ment with microbubbles only.
Effect of ultrasound on the plaque formation by HF in
Vero cells and by R849 in oral SCC cells
The HSV-1 mutant HF was fusogenic and produced large
plaques in Vero cells. The inoculation was reduced to 50
PFU. After 30 min of adsorption, cells were exposed to
ultrasound in the presence or absence of microbubbles.
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Figure 1 Effect of microbubbles on the infectivity of HSV-1. (A) Microbubbles (9.8 × 10
7/100 μl) were mixed with viral solution (1 × 10
7 PFU
of R849/900 μl). These mixtures were placed at 4°C. After incubation for 10, 30, and 60 min, the mixtures were subjected to plaque assays on
Vero cell monolayers. (B) HSV-1 strain HF was also tested for sensitivity to microbubbles. Microbubbles and 3 × 10
7 PFU of HF were mixed as
described for R849.
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greater than that of the control (Figure 3A).
The effect of ultrasound was also examined in human
oral SCC SAS cells. Cell monolayers were inoculated with
100 PFU of R849. After 30 min of adsorption, cells were
exposed to ultrasound as described for Vero cell mono-
layers. The increases in plaque numbers caused by ultra-
sound or ultrasound with microbubbles were 1.5- fold and
1.8-fold as compared with the control (Figure 3B).
The transparent base of the lumox ™ multiwall is made
of an ultra thin gas-permeable film with low autofluores-
cence [27]. Vero cells were grown on lumox ™ multiwall
plates and infected with 100 PFU of R849. When cells
were exposed to ultrasound after 30 min of adsorption in
the absence or presence of microbubbles, the mean num-
bers of plaque were increased 1.5-fold and 1.7-fold as
compared with the control (Figure 3C). The difference
between the control group and ultrasound or ultrasound
with microbubble group was significant (P < 0.05). In the
presence of microbubbles, the number of plaques was
further increased.
Effect of ultrasound intensity, duty cycle, and exposure
time on the formation of plaques by HSV- 1
In the above experiments, cells were exposed to ultrasound
under conditions used for chemotherapeutic drugs and
plasmid DNA [28,29]. To determine the optimal conditions
for HSV-1 infection, experiments were undertaken at 30
min after infection, using Vero cells and R849. First, the
duty cycle and exposure time were fixed to 10% and 20 sec,
and the ultrasound intensity was changed from 0.5 to 2.0
W/cm
2. The mean plaque number reached a maximal level
at 0.5 W/cm
2 (Figure 4A). Microbubbles further increased
the plaque number and the difference between the ultra-
sound group and ultrasound with microbubble group was
significant (P < 0.05). However, at 2.0 W/cm
2, the plaque
number was decreased as compared with the control. Cell
shrinkage and enlarged intercellular spaces were observed
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Figure 2 Effect of ultrasound on the plaque-forming ability of R849 in Vero cell monolayers. Vero cells were inoculated with 100 PFU of
R849 and incubated at 37°C for 10 (A), 30 (B), or 60 (C) min. Thereafter, cell monolayers were exposed to ultrasound in the presence (M + U) or
absence (U) of microbubbles, washed with PBS and covered with medium containing methylcellulose. After further incubation for 48 h, the
number of plaques was determined. Infected cells were also incubated in the presence of micrbubbles (M) or left untreated (Control) during the
adsorption period and used for plaque formation. Data are means ± SDs of three determinations. *P < 0.05.
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cells remained attached to the plate, whereas most cells
exposed to ultrasound were lost. Second, the output inten-
sity and exposure time were fixed to 0.5 W/cm
2 and 20 sec,
and the duty cycle was changed. A duty cycle ranging from
5% to 20% increased the plaque number, with the maxi-
mum effect achieved at 20% (Figure 4C). Microbubbles
further increased plaque numbers. At a duty cycle of 50%,
however, the plaque number decreased in the presence of
microbubbles. Third, the output intensity and duty cycle
were fixed at 0.5 W/cm
2 and 20% and the exposure time
was changed from 5 to 40 sec. The plaque numbers
reached a maximal level at 10 sec (Figure 4D). There was a
significant (P < 0.05) difference between the ultrasound
group and ultrasound with microbubble group.
Effect of ultrasound and microbubbles on the infectivity
of HSV-1
To determine whether ultrasound and microbubbles could
affect the infectivity of HSV-1 R849, viral solution (8 × 10
4
PFU/180 μl) was mixed with microbubbles (1.9 × 10
6/
20 μl) in a 24-well plate and then exposed to ultrasound
irradiation. The intensity, duty cycle and exposure time
were 0.5 W/cm
2, 20% and 10 sec, respectively. In unirra-
diated control, PBS was added instead of microbubbles.
When the mixtures were subjected to plaque assay, the
mean titers in unirradiated control, ultrasound only, and
ultrasound with microbubbles were 3.5 × 10
5 PFU/ml,
3.2 × 10
5 PFU/ml, and 3.4 × 10
5 PFU/ml, respectively.
There was no reduction of the infectivity of R849 by ultra-
sound in the presence or absence of microbubbles.
Effect of ultrasound on cell viability
To determine the effect of ultrasound on cell viability,
uninfected SAS cells were exposed to ultrasound in cell
suspensions and cell viability was measured by MTT
assay. First, the duty cycle and exposure time were fixed
to 10% and 20 sec, and output intensity was changed
from 0.5 to 2.0 W/cm
2. From 0.5 to 1.5 W/cm
2, cell via-
bility was slightly increased, but it was decreased to 89%
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Figure 3 Effect of ultrasound on the formation of plaques by HF in Vero cells, and by R849 in SAS cells. (A) Vero cells were inoculated with 50
PFU of a fusogenic HSV-1 mutant HF and cultured at 37°C for 30 min. Thereafter, cell monolayers were exposed to ultrasound in the presence or
absence of microbubbles as described in Figure 2. After further incubation, the number of plaques was determined. (B) SAS cells were inoculated with
100 PFU of R849 and cultured for 30 min. They were treated as described in (A). (C) Vero cells grown in lumox ™ multiwell plates were inoculated
with 100 PFU of R849 and cultured for 30 min. They were treated as described in (A). Data are means ± SDs of three determinations. *P < 0.05.
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Page 5 of 9of the control at an intensity of 2.0 W/cm
2 in the pre-
sence of microbubbles (Figure 5A). Second, when the
duty cycle of ultrasound was changed, cell viability
decreased to 92% of the control at a duty cycle of 50%
in the presence of microbubbles (Figure 5B). Third,
when exposure time for ultrasound was changed, cell
viability decreased to 81% of the control after exposure
for 40 sec in the presence of microbubbles (Figure 5C).
There were significant differences (P < 0.05) between
the control group and ultrasound with microbubble
group.
Discussion
Ultrasound has been studied extensively as a delivery
method for chemotherapeutic agents and plasmid DNA
because of its low invasiveness, but studies using infectious
viruses are limited. For transduction of the green fluores-
cence protein (GFP) gene, Li et al. [30] tested three ultra-
sound contrast agents, Albunex (an albumin-shelled
contrast agent composed of air-filled microbubbles), Opti-
son (a perfluorocarbon-filled contrast agent) and Levovist
(a galactose-based and air-filled contrast agent). They indi-
cated that the mean number of GFP-transfected cells was
a p p r o x i m a t e l y8 - f o l dg r e a t e ri nt h ep r e s e n c eo fO p t i s o n
than Albunex or Levovit. In the present study, we used
AS-0100 composed of a lipid shell containing perfluoro-
carbon gas. First, we tested the sensitivity of HSV-1 to the
microbubbles but found no apparent reduction in plaque-
forming ability after incubation for 60 min. Therefore, the
microbubbles did not affect the infectivity of HSV-1.
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Figure 4 Effect of ultrasound intensity, duty cycle, and exposure time on the formation of plaques by HSV-1.( A )V e r oc e l l sw e r e
inoculated with 100 PFU of R849 and incubated for 30 min. Thereafter, cell monolayers were exposed to ultrasound in the presence or absence
of microbubbles. The duty cycle and exposure time were fixed to 10% and 20 sec, and the ultrasound intensity was changed from 0.5 to 2.0 W/
cm
2, according to Sonitron intensity dial settings. After further incubation, the number of plaques was determined and the rate relative to the
control was calculated. (B) The morphology of the control and cells exposed to ultrasound at an output intensity of 2.0 W/cm
2 in the presence
of microbubbles. (C) R849-infected Vero cells were exposed to ultrasound and the number of plaques was determined as described in (A). The
output intensity and exposure time were fixed to 0.5 W/cm
2 and 20 sec and the duty cycle was changed from 5 to 50%. (D) R849-infected Vero
cells were exposed to ultrasound and the number of plaques was determined as described in (A). The output intensity and duty cycle were
fixed to 0.5 W/cm
2 and 20% and the duty cycle was changed from 5 to 40 sec. Data are means ± SDs of three determinations. *P < 0.05 vs.
control.
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Page 6 of 9Howard et al. [19] reported that an adenovirus carrying
the GFP marker gene could be transduced efficiently into
human prostate, lung and melanoma cells via ultrasound
exposure in the presence of microbubbles, but not with
ultrasound only. Ultrasound with microbubbles also
enhanced the expression of GFP encoded in AAV [21].
Although these studies demonstrated the efficiency of
gene expression by ultrasound, the effect on the entry of
the virus was not studied. In the present study, cells were
inoculated with 100 PFU of HSV-1 and exposed to ultra-
sound after different time intervals. Indeed, when cells
were exposed to ultrasound after a period of viral adsorp-
tion, the plaque number significantly increased. The
effect of ultrasound was not confined to a specific strain
of virus or cell line. Furthermore, the infectivity of R849
was not affected by ultrasound irradiation in the presence
of absence of microbubbles. Thus, we concluded that
ultrasound could accelerate the entry of oncolytic HSV-1
into oral SCC cells. Even in experiments using a lumox
™ multiwell plate with a thin fluorocarbon film, a similar
enhancement of plaque-forming activity was observed.
The findings obtained with polystylene plates may be
equivalent to those for the lumox ™ plate.
Li et al. [21] infected to human retinal pigmented
epithelial cells with AAV under ultrasound conditions,
namely, 1.0 W/cm
2, a duty cycle of 20% and an exposure
period of 20 sec and found an increase in the GFP-positive
rate from 17 to 32%. We performed experiments in a
variety of conditions and found that an intensity of
0.5 W/cm
2, duty cycle of 20% and exposure time of 10 sec
were the optimal parameters to attain a maximal number
of plaques. It is essential to optimize parameters for the
efficient transduction of HSV-1. Recently, Kopechek et al.
[31] calculated the acoustic output in a cell-well plate,
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Figure 5 Effect of ultrasound on the viability of SAS cells. (A) SAS cell suspension was exposed to ultrasound in the presence or absence of
microbubbles. Cells were incubated in 96-well plates for 48 h and cell viability was measured by MTT assay. The duty cycle and exposure time
were fixed to 10% and 20 sec and output intensity was changed from 0.5 to 2.0 W/cm
2, according to Sonitron intensity dial settings. (B) The
output intensity and exposure time were fixed to 0.5 W/cm
2 and 20 sec and duty cycle output was changed from 5 to 50%. (C) The output
intensity and duty cycle were fixed to 0.5 W/cm
2 and 10% and exposure time was changed from 10 to 40 sec. The values were divided by that
of the control and the percentage was calculated. Data are means ± SDs of three determinations. *P < 0.05 vs. control.
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Although the experimental conditions were not identical
to ours, their results must be useful to estimate the peak-
to-peak acoustic pressure at Sonitron intensity settings. Li
et al. [21] also examined the effect of the ratios of micro-
bubbles to cells and found that the percentage of transfec-
tion efficiency in 50:1 group was increased as compared
with 20:1 group. In the present study, we used microbub-
bles following the recommendation by the manufacturer,
so that the ratio of microbubbles to cells was approxi-
mately 20:1 for HSV-1 infection. Although the optimal
ratio remained to be clarified, it can be stated that the
amounts of microbubbles used were sufficient to promote
the entry of HSV-1 into epithelial cells.
In cancer therapy, the cytotoxicity of ultrasound would
concomitantly have cell-killing effects [32,33]. However,
if cell viability was impaired by sonoporation, the replica-
tion and antitumor ability of virus would be blunted. We
f o u n dt h a tu l t r a s o u n de x p o s u r ea t2W / c m
2 induced
changes in cell morphology and decreased cell viability.
Duty cycle and exposure time also affected the cell viabi-
lity. Less invasive conditions are required for efficient
HSV-1 infection. In the study of plaque assay, confluent
monolayers are required during virus adsorption. When
confluent monolayers were exposed to ultrasound,
further growth of cells is not expected and only severe
cell damage can be detectable by MTT assay. Thus, we
decided to use cell suspension and plated the cells after
ultrasound for MTT assay. The re-plated cells prolifer-
ated at a similar rate as unirradiated cells, if the intensity,
duty cycle and time were within a range. This is consis-
tent with the result of plaque assay in which monolayers
were used and no cytotoxic alteration of cell morphology
occurred except for the condition at high ultrasound
intensity (Figure 4B). Although the difference in exposure
conditions including cell adhesion and well size may yield
distinctly different results, it is unlikely that ultrasound
induces lytic changes of the cell membrane to facilitate
the virus entry. If this is the case, the number and size of
plaques formed in Vero and SAS cell monolayers would
be reduced, because plaque formation is dependent on
the viability of cells.
In HSV-1 infection, as an initial step, glycoproteins gB
and gC bind to heparin sulfate proteoglycans on the cell
surface, attaching the virus to the host cell. Once the
viral and host cell membranes are brought close to each
other, glycoprotein gD can associate with any of a num-
ber of cell receptors including herpesvirus entry mediator
(HVEM), nectin-1 and 3-O-sulfated heparin sulfate to
trigger fusion. However, at least three pathways are
implicated in HSV-1’s entry into different types of sus-
ceptible cells: direct fusion with the host cell membrane,
endocytosis followed by fusion with an acidic endosome,
and endocytosis followed by fusion with a neutral
endosome [34-36]. Taylor et al. [20] introduced envel-
ope-deficient retroviral vectors into human rhabdomyo-
sarcoma cells, suggesting that an unenveloped-retrovirus
could enter the cells through ultrasound-generated pores
of the plasma membrane. We found efficient entry by
ultrasound, and a further increase with microbubbles. It
is possible that the ultrasound-induced formation of
pores contributes to the entry of HSV-1. If so, a similar
increase in plaque number should be observed, irrespec-
tive of the adsorption period. However, ultrasound pro-
duced more plaques after 30 min of adsorption than 10
min of adsorption. For example, the increases in cultures
treated after 10 or 30 min of adsorption were 10 and 27
PFU, respectively (Figure 2a, b). Thus, another mechan-
ism would be present. In this regard, Hernot and Kliba-
nov [37] proposed the involvement of active transport
mechanisms, such as endocytosis and phagocytosis, in
t h eu p t a k eo fm i c r o b u b b l e su n d e ru l t r a s o u n d .I nt h e
entry of HSV-1 that attaches to the cell surface, endocy-
tosis may be promoted by ultrasound. These in vitro data
must be useful to demonstrate the efficacy of sonopora-
tion in introducing R849 and HF into oral SCC xeno-
grafts in nude mice.
Conclusion
The exposure of Vero cells and oral SCC cells to ultra-
sound can accelerate the process of HSV-1 infection.
Microbubbles further enhanced the effect of ultrasound.
Ultrasound may be useful to enhance the efficiency of
HSV-1 infection in oncolytic virotherapy for oral SCC.
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